IP Verse

Compositions Comprising Omega-3 Polyunsaturated And Medium Chain Fatty Acids - EP3709817

The patent EP3709817 was granted to Hills PET Nutrition on Oct 22, 2025. The application was originally filed on Nov 17, 2017 under application number EP17818344A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3709817

HILLS PET NUTRITION
Application Number
EP17818344A
Filing Date
Nov 17, 2017
Status
Patent Maintained As Amended
Sep 19, 2025
Grant Date
Oct 22, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

NESTLEAug 10, 2023PLOUGMANN VINGTOFTADMISSIBLE

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONCA2849218
EXAMINATIONCN102159197
EXAMINATIONUS2008220126
EXAMINATIONUS2015139920
EXAMINATIONUS2016249646
EXAMINATIONWO03075670
EXAMINATIONWO2008149177
EXAMINATIONWO2011014363
EXAMINATIONWO2017050666
INTERNATIONAL-SEARCH-REPORTUS2013274335
INTERNATIONAL-SEARCH-REPORTUS2014343146
INTERNATIONAL-SEARCH-REPORTUS2017135974
INTERNATIONAL-SEARCH-REPORTWO2015013678
INTERNATIONAL-SEARCH-REPORTWO2017117091
OPPOSITIONEP3458046
OPPOSITIONUS8388999
OPPOSITIONUS8637495
OPPOSITIONWO2015069215
OPPOSITIONWO2017117091
OPPOSITIONWO2017199223

Non-Patent Literature (NPL) Citations (20) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "CAPTEX 355 Technical Data Sheet ", ABITEC, (20121108), pages 1 - 2, XP093103305-
OPPOSITION- Anonymous, "Fats and other Lipids ", Anonymous, Audrey H. Ensminger M. E. Ensminger James E. Konlande John R. K. Robson, Foods & Nutrition Encyclopedia 2nd edition Volume 1 A-H, CRC Press, (19940101), vol. 1, pages 694 - 694, XP093103301-
OPPOSITION- Anonymous, "MEG-3TM 0355TG Production data sheet ", DSM, (20130618), pages 1 - 3, XP093103311-
OPPOSITION- Anonymous, "Purina Pro Plan nutrition that performs ", (20150101), pages 1 - 6, Purina , URL: https://www.oakhurstveterinaryhospitalca.com/assets/pdfs/Purina%20Dog%20Nutrition/Purina%20ProPlan%20Product%20Guide.pdf, (20231120), XP093103290-
OPPOSITION- Anonymous, "Small Animal Nutrition", Anonymous, Joanna M. Bassert , John Thomas, Clinical Textbook for Veterinary Technicians Eighth Edition, Saunders, (20140101), pages 299 - 299, ISBN 978-1437726800, XP093102117-
OPPOSITION- M. C Berenbaum, "Synergy, additivism and antagonism in immunosuppression", Clinical and experimental immunology, Wiley-Blackwell Publishing Ltd., GB, GB , (19770401), vol. 28, no. 1, ISSN 0009-9104, pages 1 - 18, XP055246276-
OPPOSITION- Julie Foucquier, Guedj Mickael, "Analysis of drug combinations: current methodological landscape", Pharmacology Research & Perspectives, John Wiley & Sons Ltd., GB, GB , (20150601), vol. 3, no. 3, doi:10.1002/prp2.149, ISSN 2052-1707, pages 1 - 11, XP055462926
OPPOSITION- Duarte Diana, Vale Nuno, "Evaluation of synergism in drug combinations and reference models for future orientations in oncology", Current Research in Pharmacology and Drug Discovery, (20220101), vol. 3, doi:10.1016/j.crphar.2022.100110, ISSN 2590-2571, page 100110, XP093055997
OPPOSITION- Carlson Sarah J., Nandivada Prathima, Chang Melissa I., Mitchell Paul D., O’loughlin Alison, Cowan Eileen, Gura Kathleen M., Nose Vania, Bistrian Bruce R., Puder Mark, "The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice", Metabolism, US , (20150201), vol. 64, no. 2, doi:10.1016/j.metabol.2014.10.005, ISSN 0026-0495, pages 1 - 18, XP093103294
OPPOSITION- Kono, H. ; Fujii, H. ; Ishii, K. ; Hosomura, N. ; Ogiku, M., "Dietary medium-chain triglycerides prevent chemically induced experimental colitis in rats", Translational research, NL , (20100301), vol. 155, no. 3, doi:10.1016/j.trsl.2009.08.011, ISSN 1931-5244, pages 131 - 141, XP026910785
OPPOSITION- Yuanlong Pan, Brian Larson, Joseph A. Araujo, Winnie Lau, Christina De Rivera, Ruben Santana, Asa Gore, Norton W. Milgram, "Dietary supplementation with medium-chain TAG has long-lasting cognition-enhancing effects in aged dogs", British Journal of Nutrition, UK , (20100601), vol. 103, no. 12, doi:10.1017/S0007114510000097, ISSN 0007-1145, pages 1746 - 1754, XP055449498
OPPOSITION- Trebble Timothy, Arden Nigel K., Stroud Mike A., Wootton Stephen A., Burdge Graham C., Miles Elizabeth A., Ballinger Anne B., Thompson Rachel L., Calder Philip C., "Inhibition of tumour necrosis factor-α and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation", British Journal of Nutrition, UK, UK , (20030801), vol. 90, no. 2, doi:10.1079/BJN2003892, ISSN 0007-1145, pages 405 - 412, XP093244204
OPPOSITION- Philip C Calder, "n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases", American Journal of Clinical Nutrition, Elsevier, (20060601), vol. 83, no. 6, Suppl., doi:10.1093/ajcn/83.6.1505S, ISSN 0002-9165, pages 1505S - 1519S, XP055347316
OPPOSITION- Philip C. Calder, "Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?", British journal of clinical pharmacology, GB , (20130205), vol. 75, no. 3, doi:10.1111/j.1365-2125.2012.04374.x, ISSN 0306-5251, pages 645 - 662, XP071600927
OPPOSITION- Geary Nori, "Understanding synergy", AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM., AMERICAN PHYSIOLOGICAL SOCIETY, BETHESDA, MD., US, US , (20130201), vol. 304, no. 3, doi:10.1152/ajpendo.00308.2012, ISSN 0193-1849, pages E237 - E253, XP093244201
OPPOSITION- T.-C. Chou, "Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method", Cancer research, (20100115), vol. 70, no. 2, doi:10.1158/0008-5472.CAN-09-1947, ISSN 00085472, pages 440 - 446, XP055169871
OPPOSITION- Skouroliakou Maria, Konstantinou Dimitris, Agakidis Charalampos, Kaliora Andriana, Kalogeropoulos Nick, Massara Paraskevi, Antoniadi Marina, Panagiotakos Demosthenes, Karagiozoglou‐lampoudi Thomais, "Parenteral MCT/ω‐3 Polyunsaturated Fatty Acid-Enriched Intravenous Fat Emulsion Is Associated With Cytokine and Fatty Acid Profiles Consistent With Attenuated Inflammatory Response in Preterm Neonates : A Randomized, Double‐Blind Clinical Trial", Nutrition in clinical practice, US , (20160401), vol. 31, no. 2, doi:10.1177/0884533615602011, ISSN 0884-5336, pages 235 - 244, XP093102124
OPPOSITION- Jean A. Hall, Dennis E. Jewell, "Feeding Healthy Beagles Medium-Chain Triglycerides, Fish Oil, and Carnitine Offsets Age-Related Changes in Serum Fatty Acids and Carnitine Metabolites", PLoS ONE, vol. 7, no. 11, doi:10.1371/journal.pone.0049510, pages e49510 - 16, XP055396819
OPPOSITION- Bauer John E, "Therapeutic use of fish oils in companion animals", J Am Vet Med Assoc, (20111201), vol. 239, no. 11, doi:10.2460/javma.239.11.1441, pages 1441 - 1151, XP093102118
OPPOSITION- Mañé Josep, Pedrosa Elisabet, Lorén Violeta, Ojanguren Isabel, Fluvià Lourdes, Cabré Eduard, Rogler Gerhard, Gassull Miquel A., "Partial Replacement of Dietary (n-6) Fatty Acids with Medium-Chain Triglycerides Decreases the Incidence of Spontaneous Colitis in Interleukin-10-Deficient Mice", The Journal of Nutrition, US , (20090301), vol. 139, no. 3, doi:10.3945/jn.108.101170, ISSN 0022-3166, pages 603 - 610, XP093102121

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents